AUTOLIV INC (ALV)

Anavex Life Sciences (NASDAQ:AVXL – Get Free Report) announced its quarterly earnings data on Thursday. The biotechnology company reported ($0.06) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.07) by $0.01, FiscalAI reports.

Autoliv, Inc. has reported its second-quarter and half-year 2026 results, with sales rising to US$2,803 million for the quarter and US$5,556 million for the half-year, while net income and earnings per share from continuing operations were lower than the same periods last year.

Allianz reported an EPS of $197.957 in its last earnings report, beating expectations of $160.333. Following the earnings report the stock price went same 0%. Which hedge fund is a major shareholder of Allianz? Currently, no hedge funds are holding shares in MX:ALVN

Get real-time Autoliv Inc. (ALV) stock price, news, financials, community insights, and trading ideas. Join 10 million+ investors and traders tracking markets in real-time on Stocktwits.

The stock looks inexpensive, the company is still generating healthy cash flow and management maintained its 2026 margin outlook. The issue is timing. Much of the margin improvement is expected later in the year, leaving investors to weigh attractive valuation metrics against execution risk in a wea…